$0.5580
0.0611.16%
At close: -
Comments
Loading...
Lineage Cell Therapeutics (AMEX:LCTX) Stock, Earnings Estimates, EPS, And Revenue
Lineage Cell Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Mar 6
EPS Estimate
$-0.020
Quarterly Revenue Estimate
$1.3M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$8.7M
Analyze the earnings history of Lineage Cell Therapeutics using advanced sorting and filters.
Data brought to you by Benzinga APIs
Lineage Cell Therapeutics (LCTX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-14 | $-0.02 | $-0.03 | 33.3 % |
| Jun 2024 | 2024-08-08 | $-0.03 | $-0.04 | 25.0 % |
| Mar 2024 | 2024-05-09 | $-0.04 | $-0.04 | 0.00 % |
| Dec 2023 | 2024-03-07 | $-0.03 | $-0.04 | 25.0 % |
Lineage Cell Therapeutics (LCTX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Sep 2024 | 2024-11-14 | $3.78M | $886.57K | 326.3 % |
| Jun 2024 | 2024-08-08 | $1.41M | $970.00K | 45.1 % |
| Mar 2024 | 2024-05-09 | $1.44M | $1.36M | 6.18 % |
| Dec 2023 | 2024-03-07 | $2.10M | $1.31M | 60.3 % |
FAQ
When is Lineage Cell Therapeutics (AMEX:LCTX) reporting earnings?
Lineage Cell Therapeutics (LCTX) is scheduled to report earnings on March 6, 2025. The last reported earnings were for reported on November 14, 2024 for Q3.
What were the latest earnings per share (EPS) for Lineage Cell Therapeutics (AMEX:LCTX)?
The Actual EPS was $-0.02, which beat the estimate of $-0.03.
What were Lineage Cell Therapeutics’s (AMEX:LCTX) revenues?
The Actual Revenue was $3.8M, which beat the estimate of $886.6K.
Browse earnings estimates, EPS, and revenue on all stocks.